Nerve Growth Factor Antagonists: Is the Future of Monoclonal Antibodies Becoming Clearer?
Crossref DOI link: https://doi.org/10.1007/s40265-017-0781-6
Published Online: 2017-06-28
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bannwarth, Bernard http://orcid.org/0000-0001-9605-1838
Kostine, Marie
Text and Data Mining valid from 2017-06-28